Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report.
Abdulrahman QatomahMajidah BukhariEdward CuplerHosam AlardatiMohammad MawardiPublished in: Journal of medical case reports (2021)
This case highlights possible direct-acting antiviral agent-induced rhabdomyolysis in a patient with very-long-chain acyl-CoA dehydrogenase deficiency, presumably through alteration of mitochondrial membrane potential. Further studies are required to assess the possible impact and associations.
Keyphrases
- hepatitis c virus
- acute kidney injury
- drug induced
- liver failure
- fatty acid
- human immunodeficiency virus
- oxidative stress
- high glucose
- respiratory failure
- diabetic rats
- case report
- replacement therapy
- intensive care unit
- hepatitis b virus
- case control
- climate change
- acute respiratory distress syndrome
- smoking cessation
- mechanical ventilation